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Stilbenoids are a group of polyphenolic compounds found in plants, trees, berries and nuts. 
Stilbenoids have been shown to serve an anti-microbial and anti-fungal function in plants. 
There is also evidence that as a part of human diet, stilbenoids play an important role as 
antioxidants and may have anti-inflammatory effects. The PI3K/Akt pathway is a well-
characterized signaling pathway controlling cellular functions involved in growth and cell 
cycle, and in metabolism. There is also increasing evidence to show the involvement of this 
pathway in the regulation of inflammatory responses. In the present study, an attempt was 
made to investigate the anti-inflammatory properties of naturally occurring stilbenoids 
pinosylvin (1), monomethyl pinosylvin (2), resveratrol (3), pterostilbene (4), piceatannol (5) 
and rhapontigenin (6). Glycosylated derivatives of piceatannol and rhapontigenin, namely 
astringin (7) and rhaponticin (8), respectively, were also investigated. In addition to the 
natural stilbenoids, pinosylvin derivatives (9-13) were synthesized and subjected to the 
testing of their effects on PI3K/Akt pathway in inflammatory conditions.  
The investigated natural stilbenoids (except the glycosylated derivatives) were found to 
down-regulate Akt phosphorylation, which is a well acknowledged marker for PI3K activity. 
It was also found that all of the studied natural stilbenoids had anti-inflammatory effects in 
vitro. The three most potent stilbenoids, piceatannol, pinosylvin and pterostilbene were 
selected for in vivo testing and were found to suppress the inflammatory edema and to down-
regulate the production of inflammatory mediators IL6 and MCP1 in carrageenan-induced 
paw inflammation in the mouse. When compared to the commercial PI3K inhibitor 
LY294002, the anti-inflammatory effects appeared to be quite similar. The results reveal 
hitherto unknown anti-inflammatory effects of natural stilbenoids and suggest that those 
effects may be mediated via inhibition of the PI3K/Akt pathway.  
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Stilbenoids are a group of polyphenolic compounds found in nature and particularly in plants. 
Stilbenoids have been shown to have anti-microbial and anti-fungal properties and it is likely 
that their role in plants is to serve as defensive compounds against microbial pathogens.
1
 
They are synthesized in trees as secondary metabolites during heartwood biogenesis and they 
are also actively produced as a response to infection or injury. Stilbenoids can therefore be 
also classified as phytoalexins due to their antimicrobial properties.
2,3
  
Due to being abundant in plants, stilbenoids are also present in human nutrition. Their health 
effects and nutritional significance has also been studied. Resveratrol, probably the most 
well-known and investigated stilbenoid, is present in grapes, different berries, nuts and also in 
red wine.
4
 Resveratrol has been reported to have anti-inflammatory, anti-carcinogenic, anti-
oxidative and cardioprotective properties.
5
 However, in addition to resveratrol, several other 
stilbenoid compounds are present in human nutrition. For instance, pterostilbenoid, 
rhapontigenin and piceatannol can all be found in different berries, fruits, nuts and other 
edible plants.
6-10
 Structurally very closely related stilbenoids, pinosylvin and monomethyl 
pinosylvin, are also readily found in pine knots
11
 and also in pine nuts.
12
 There are 
fragmentary data on the health promoting effects of those stilbenoids, sometimes resembling 
the effects of resveratrol
13
 including some anti-inflammatory effects.
14-16
 
The PI3K/Akt pathway is a cellular signaling pathway involved in various cellular processes, 
such as cell proliferation, migration and survival as well as glucose metabolism. It is also 
considered to have a remarkable role in inflammatory responses
17
 and its role in cancer is 
also vastly studied.
18
 The PI3K/Akt pathway consists of phosphatidylinositol 3-kinases that 
catalyze the phosphorylation of phosphatidylinositols, a class of structurally important lipid 
molecules in cell membranes. The phosphatidylinositolphosphates (PIPs) generated in the 
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process then serve as a docking platform for Akt kinase (also known as PKB). Akt kinase is a 
serine/threonine kinase that has a wide range of downstream targets regulating different 
processes, such as cell proliferation, glucose metabolism, neuronal development as well as 
inflammation.
19-21
 It has been shown that when the PI3K/Akt pathway is inhibited with 
pharmacological compounds, the cellular inflammatory responses are attenuated due to 
down-regulation of inflammatory genes.
22-24
 
The aim of the present study was to investigate natural stilbenoids (Figure 1), including: 
pinosylvin (1), monomethyl pinosylvin (2), resveratrol (3), pterostilbene (4), piceatannol (5) 
and rhapontigenin (6) and test their effects on the PI3K/Akt pathway in activated 
macrophages. Additionally, the glycoside derivatives of piceatannol and rhapontigenin, 
namely, astringin (7) and rhaponticin (8), respectively, were investigated. In addition to the 
natural stilbenoids, pinosylvin derivatives (9-13) were synthesized and subjected to the anti-
inflammatory testing. Another aim was to investigate the effects of the aforementioned 
stilbenoids on the production of the inflammatory mediators interleukin 6 (IL6), monocyte 
chemotactic protein 1 (MCP1) and nitric oxide (NO). Further, the anti-inflammatory effects 
of three potent stilbenoids (piceatannol, pinosylvin and pterostibene) were also investigated 
in vivo in the carrageenan-induced paw inflammation model in the mouse. Additionally the in 
vivo studies were backed up with ex vivo studies by measuring inflammatory cytokines in the 
inflamed paw tissue. The results reveal that all of the investigated natural stilbenoids 
(excluding the glycoside derivatives) have an inhibitory effect on the activation of the 
PI3K/Akt pathway. It was also found that these compounds down-regulate the production of 
inflammatory mediators, possibly via a PI3K/Akt dependent mechanism. An anti-
inflammatory effect was also observed in the in vivo model and was further elucidated with 
ex vivo studies.  
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Synthesis of pinosylvin derivatives 
A panel of pinosylvin derivatives bearing different alkyloxy and allyloxy moieties 
(compounds 9-13) was designed (Figure 1). The compounds were synthesized by a 
nucleophilic substitution reaction between the commercially available pinosylvin and 
different alkyl (Et, n-Pr, Bn, and i-Bu) and allyl bromide in the presence of potassium 
carbonate as a base in acetone. The novel pinosylvin ethers were produced in low to moderate 
yields.
25




C NMR spectroscopy. 
Natural stilbenoids inhibited PI3K/Akt activation in a concentration-dependent manner 
in J774 macrophages 
Stimulation of macrophages through a TLR4-mediated mechanism by exposing the cells to 
bacterial endotoxin LPS (10 ng/mL) induced PI3K-mediated phosphorylation of Akt protein 
on amino acid residue S473 and treating the cells with the commercial PI3K inhibitor 
LY294002 inhibited Akt phosphorylation (Figure 2). Next, the effects of natural stilbenoids 
pinosylvin (1), monomethyl pinosylvin (2), resveratrol (3), pterostilbene (4), piceatannol (5) 
and rhapontigenin (6) on the phosphorylation of Akt in activated macrophages were 
investigated. The results showed that all of the investigated stilbenoids inhibited Akt 
phosphorylation in a concentration-dependent manner (Fig 3 A-F). Piceatannol (5) was the 
most potent of the tested stilbenoids followed by monomethyl pinosylvin (2) and pinosylvin 
(1) which all inhibited Akt phosphorylation in a statistically significant manner already at 3 
µM concentrations while rhapontigenin (6) appeared to be the least potent in the series of the 
natural stilbenoids. The glycoside derivatives of piceatannol and rhapontigenin, i.e., astringin 
(7) and rhaponticin (8), respectively, were also investigated. The glycosides had no effect on 
Akt phosphorylation (Fig 3). 
Page 5 of 32
ACS Paragon Plus Environment































































Semi-synthetic pinosylvin derivatives exhibited a structure-related loss of effect on Akt 
phosphorylation when compared to natural stilbenoids 
In order to compare the effects of natural stilbenoids versus synthetic pinosylvin derivatives, 
Akt phosphorylation was stimulated with LPS in J774 macrophages treated with the 
pinosylvin derivatives 9-13. Pinosylvin (1) was used as a reference compound in the 
experiments. It was found that although some of the synthetic stilbenoid derivatives inhibited 
Akt phosphorylation the effect was not comparable in magnitude to the effect of the natural 
stilbenoid pinosylvin (Fig 4): Monoethyl pinosylvin (9) and monoallyl pinosylvin (11) 
reduced Akt phosphorylation in a statistically significant manner when used at 30 µM 
concentrations. Monoisobutyl pinosylvin (12) and monobenzyl pinosylvin (13) had no effect 
at 30 µM concentrations while monopropyl pinosylvin (10) appeared to have a small 
inhibitory effect but it did not reach statistical significance.  The loss of effect appeared to 
correlate with the length of the carbon side chain on the hydroxy group connected to the R1 
position in the phenyl ring. 
 
Natural stilbenoids down-regulated the production of inflammatory mediators NO, IL6 
and MCP1 in J774 macrophages 
In order to investigate the effects of the natural stilbenoids 1-8 on the production of 
inflammatory mediators NO, IL6 and MCP1 in activated macrophages, the J774 macrophage 
cells were stimulated with LPS in the presence of increasing concentrations of the stilbenoids 
for 24 hours prior to cell culture media collection. It was found that the investigated 
stilbenoids had a concentration-dependent inhibitory effect on the production of the 
aforementioned inflammatory mediators, and that was comparable to the effects obtained 
with the known PI3K inhibitor LY294002. (Figures 5-7) 
Page 6 of 32
ACS Paragon Plus Environment































































The control compound LY294002 inhibited NO production by 50% at 8.9 µM concentration. 
Closely comparable values were obtained for resveratrol (3, 12.15 µM), pterostilbene (4, 16.7 
µM) and pinosylvin (1, 16.6 µM). Clearly higher values were obtained for monomethyl 
pinosylvin (2, 37.0 µM) and rhapontigenin (6, 102.8 µM). For piceatannol (5) the value was 
the lowest (2.6 µM). (Figure 5) 
LY294002 inhibited IL6 expression half-maximally at 5.1 µM concentration. Comparable to 
this were resveratrol (3, 6.8 µM), pterostilbene (4, 8.7 µM) and piceatannol (5, 13.0 µM). 
Higher values were detected with pinosylvin (1, 32.1 µM), monomethyl pinosylvin (2, 30.2 
µM) and rhapontigenin (6, 99.1 µM). (Figure 6) 
For MCP1 production, LY294002 had a 50% inhibitory effect at 3.7 µM. The only stilbenoid 
comparable to that was piceatannol (5, 4.0 µM) and perhaps pterostilbene (4, 10.5 µM). 
Clearly higher values were found for pinosylvin (1, 38.7 µM), monomethyl pinosylvin (2, 
23.7 µM), resveratrol (3, 13.6 µM) and rhapontigenin (6, 19.4 µM). (Figure 7) 
In contrast, the glycoside derivatives of piceatannol and rhapontigenin, i.e., astringin (7) and 
rhaponticin (8), respectively, appeared to have lost their activity when compared to the 
corresponding non-glycosylated stilbenoid (Figures 5-7). 
Natural stilbenoids showed anti-inflammatory effects both in vivo and ex vivo 
Carrageenan-induced paw edema mouse model was used as an in vivo model of inflammation 
to investigate the anti-inflammatory effects of natural stilbenoids. Pinosylvin (1), 
pterostilbene (4) and piceatannol (5) were selected for the in vivo studies due to them having 
similar effects and relatively similar inhibition percentages in the in vitro studies than the 
PI3K inhibitor LY294002. Also, based on the literature search pterostilbene (4) and 
piceatannol (5) appeared also to be the least investigated stilbenoids with very little published 
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data from in vivo experiments. A widely used anti-inflammatory drug dexamethasone was 
used as the control compound. It was found that all of the investigated natural stilbenoids, 
i.e., 1, 4 and 5 (when given at the dose of 30 mg/kg), had an anti-inflammatory effect in vivo 
comparable to that of LY294002 (15 mg/kg) and dexamethasone (2 mg/kg), (Figure 8). 
In addition to the in vivo studies, ex vivo studies were conducted by measuring the levels of 
inflammatory cytokines IL6 and MCP1 in the mouse paw tissue after carrageenan injection. It 
was found that the inflamed paw tissue from mice treated with either stilbenoids or the 
control compounds LY294002 or dexamethasone showed a diminished inflammatory 
response, which was seen as lower expression of the inflammatory cytokines IL6 and MCP1 
(Figure 9). 
  
Page 8 of 32
ACS Paragon Plus Environment
































































In the present study, our aim was to investigate anti-inflammatory properties of natural 
stilbenoids pinosylvin (1), monomethyl pinosylvin (2), resveratrol (3), pterostilbene (4), 
piceatannol (5), rhapontigenin (6), astringin (7) and rhaponticin (8).The hypothesis was that 
stilbenoids would down-regulate inflammatory gene expression and the activity of the 
PI3K/Akt pathway in relation to inflammation. The results obtained in this study support the 
idea that natural stilbenoids have anti-inflammatory properties and the effect is possibly 
mediated via inhibition of the PI3K/Akt pathway. Further, it was found that the investigated 
semi-synthetic pinosylvin derivatives showed weaker effects on PI3K/Akt pathway in 
inflammatory conditions when compared to their naturally occurring counterparts. 
The health-beneficial properties of the stilbenoid resveratrol and red wine have been a 
popular research topic ever since the concept of the French paradox was formulated in the 
1980s.
26
 Reports have shown that resveratrol has anti-inflammatory, anti-carcinogenic, anti-
oxidative and cardioprotective properties
5
 as well as beneficial effects on aging, diabetes and 
neurological dysfunction.
27
 The in vitro anti-inflammatory effects of resveratrol were also 
reproduced in the present study. However, there exists a plethora of foodstuffs containing 
stilbenoids other than resveratrol, such as different berries, nuts and other edible plants which 
are a natural part of human nutrition worldwide. Therefore, in this study we focused mainly 
on other stilbenoids besides resveratrol, namely pinosylvin (1), monomethyl pinosylvin (2), 
pterostilbene (4) piceatannol (5), and rhapontigenin (6) as well as five synthetic derivatives of 
pinosylvin. 
The PI3K/Akt signaling pathway controls an array of cellular functions, some of which are 
also involved in inflammation. Regarding inflammation, the PI3K/Akt pathway is 
documented to regulate survival, motility, differentiation and proliferation of leukocytes via 
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cytokine and chemokine signaling as well as NF-κB mediated transcription.
21
 Among three 
different classes of PI3Ks there also exists several different PI3K isoforms. The class I PI3Ks 
are considered to be involved in inflammation and particularly class I PI3K subunits PI3Kδ 




Low-grade chronic inflammation has been documented to be increasingly prevalent 
especially in western countries. Western lifestyle and diet has been suggested as one of the 
main causes of low-grade inflammation and the prevalence of metabolic syndrome and type 2 
diabetes is considered to be a direct effect caused by low-grade inflammation.
29
 Obesity is 
also known to up-regulate inflammation and it has been reported that macrophages located in 
the adipose tissue produce significant amounts of IL6 and MCP1 as well as other 
inflammatory mediators.
30
 It has also been documented that a healthy diet containing 
phytonutrients from fruits and vegetables modulates low-grade inflammation towards a more 
healthy level.
31
 A recent study also documented that the PI3K/Akt pathway is activated in 
low-grade inflammation and that the inflammation can be attenuated with PI3K inhibition.
32
 
Based on our present findings we hypothesize that a diet containing natural stilbenoids could 
possibly also attenuate low-grade inflammation via a PI3K-dependent mechanism. 
In this study we used a commercially available PI3K inhibitor LY294002 as a reference 
compound for PI3K inhibition. LY294002 is a well-characterized class I PI3K inhibitor.
33
 
The phosphorylation of Akt is often considered as a marker for PI3K activity. Upon binding 
the phosphatidylinositols produced by PI3Ks, Akt is docked to the cell membrane, which 
allows PDK1 and MTOR to phosphorylate it.
20
 Our results show that the control compound 
PI3K inhibitor LY294002 used in this study, inhibits Akt phosphorylation upon LPS 
stimulation also in activated macrophages and inhibits the production of inflammatory 
cytokines IL6 and MCP1 in vitro and in vivo as expected. 
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Based on our findings, it appears that the investigated stilbenoids also exhibit similar 
inhibitory effects as the PI3K inhibitor LY294002 on the phosphorylation of Akt indicative 
of the inhibition of the activity of the PI3K/Akt pathway. These data are supported by the few 
studies that have focused on the effects of stilbenoids on the PI3K/Akt pathway in other cell 
types and experimental settings.
14,34,35
 However, the findings reported in this study suggest 
that among the investigated stilbenoids there are differences regarding the PI3K/Akt 
inhibition potency. Piceatannol (compound 5) appeared to be the most potent of the tested 
natural stilbenoids, followed by pinosylvin (compound 1) and monomethyl pinosylvin 
(compound 2) while rhapontigenin (compound 6) was the least potent. Very similar pattern of 
activity was also seen in their inhibitory effects on the production of the inflammatory factors 
nitric oxide, IL6 and MCP1, see below. 
The semi-synthetic pinosylvin derivatives were less potent than the natural stilbenoid 
pinosylvin, and the loss of activity seemed to associate with the length of the side chain on 
the R1 position in the left-hand side phenyl ring. When the pinosylvin derivatives were 
compared to the natural pinosylvin, it appeared that a small substituent such as methyl on the 
R1 carbon did not significantly effect the potency of PI3K/Akt inhibition as was documented 
with monomethyl pinosylvin (compound 2). However, when the substituent on R1 became 
longer, such as the ethyl, propyl or isobutyl ether group on compounds 9, 10 and 12, 
respectively, or bulkier such as the allyl or benzyl ether groups on compounds 11 and 13, 
respectively, the effect observed on PI3K/Akt inhibtion was clearly weakened. In fact, 
compounds 12 and 13 had no effect at 30 µM concentrations, and compound 10 had a minor 
effect which did not reach statistical significance. This is possibly due to the fact that longer 
or bulkier substituents are more likely to cause steric hindrance in the interaction mechanisms 
between these molecules.  
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In addition, the glycosidic derivatives of piceatannol and rhapontigenin, namely astringin and 
rhaponticin, respectively, did not appear to have an effect on the PI3K/Akt pathway. This is 
possibly due to the same mechanism described above and / or related to the fact that 
glycoside derivatives are not readily transported into the cells but rather stay in the cell 
culture medium where they remain inactive. To further elucidate this, it would be meaningful 
to investigate other different glycosidic derivatives (eg. glycosides with galactose or fructose 
conjugates) because both of the tested compounds were O-beta-D-glycoside derivatives of 
the stilbenoids in question. 
Nitric oxide produced by inducible nitric oxide synthase (iNOS) as well as the cytokines IL6 
and MCP1 are well known inflammatory mediators. Piceatannol (compound 5) was the most 
potent of the tested stilbenoids in decreasing nitric oxide production while rhapontigenin 
(compound 6) was the least potent of the non-glycosylated stilbenoids; and the potency of the 
other non-glycosylated stilbenoids was between those two. The glycosylated stilbenoids 
astringin (compound 7) and rhaponticin (compound 8) did not have any effect. Very similar 
pattern of activity was also seen in their inhibitory effects on Akt phosphorylation, and IL6 
and MCP1 production. Rhapontigenin (6) is the only aglycone which has a methyl group at 
position C4 while piceatannol (5) has hydroxy groups in positions R1, R3, R4 and R5 which 
may contribute to their anti-inflammatory activity. The glycosylated stilbenoids remained 
ineffective possibly because they are not readily transported into the cells which is necessary 
for their effects on the production of inflammatory mediators. 
The production of IL6, MCP-1 and nitric oxide is activated by various inflammatory stimuli 
and also different transcription factors are documented to be involved. The cellular effects of 
PI3K are occasionally reported to be mediated via the NF-κB transcription factor and the 
three measured inflammatory mediators are also reported to be NF-κB responsive.
36-39
 Our 
findings document that inhibition of PI3K/Akt pathway with LY294002 down-regulates the 
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expression of these inflammatory mediators, which in turn suggests that these inflammatory 
mediators are PI3K/Akt responsive. It was also found that the natural stilbenoid compounds 
investigated in the present study down-regulated the expression of these inflammatory 
mediators. When these data are considered alongside with our findings that the stilbenoids 
also inhibited PI3K/Akt activation, it is plausible that the down-regulated inflammatory 
response is mediated via PI3K inhibition. 
Carrageenan-induced paw edema is a well-characterized in vivo model of acute inflammation. 
It has been widely reported that the inflammatory factors mediating carrageenan-induced 
edema include IL6, MCP1 and NO.
40-42
 The PI3K/Akt pathway is also considered to be one 
of the signaling pathways involved in acute inflammation such as the inflammatory edema 
caused by exposure to carrageenan. We and others have earlier documented that inhibition of 
the PI3K/Akt pathway leads to reduced edema and decreased inflammatory cell migration 
upon carrageenan irritation.
21,24
 These data support the idea that PI3K/Akt signaling is 
involved in mediating the formation of the inflammatory response induced by exposure to 
carrageenan. In the present study, we found that the investigated natural stilbenoids also 
reduced the carrageenan-induced edema and suppressed the expression of the inflammatory 
cytokines IL6 and MCP1 in the inflamed paw tissue. According to our knowledge, this is a 
novel in vivo effect for pterostilbene (4) and piceatannol (5) that has not been previously 
reported. The effect appears to be comparable to the effect obtained with the commercial 
PI3K inhibitor LY294002. This in turn suggests that the investigated stilbenoids would have 
anti-inflammatory properties in vivo and that the mechanism of the effect possibly includes 
an inhibitory interaction with the PI3K/Akt pathway. 
In this study we document our findings regarding several naturally occurring stilbenoid 
compounds, i.e. pinosylvin, monomethyl pinosylvin, resveratrol, pterostilbene, piceatannol 
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and rhapontigenin, which are all known to be included in a normal healthy human diet. It was 
found that these stilbenoids have anti-inflammatory properties when investigated in vitro and 
in vivo along with their inhibitory action on the PI3K/Akt signaling pathway. The effects 
were comparable to the effects obtained with the known PI3K/Akt inhibitor LY294002. 
Additionally, we found that the tested glycoside derivatives of these stilbenoids did not have 
a significant effect in the inflammatory models. Based on these findings it appears that the 
naturally occurring stilbenoids included in human nutrition have anti-inflammatory properties 
and it also appears that these effects could possibly be mediated via the PI3K/Akt pathway. 
This may be a significant finding that could be exploited to alleviate inflammatory conditions 
by a stilbenoids-containing dietary intervention but further studies are needed to understand 
the mechanisms of action and to prove bioavailability and actual clinical efficacy in man. 
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The reagents used in the study were obtained as following: pAkt S473 and Akt antibodies 
from Cell Signaling Technology, Danvers, MA, USA; β-actin antibodies and HRP-
conjugated goat polyclonal anti-rabbit IgG antibodies from Santa Cruz Biotechnology, Santa 
Cruz, CA, USA; PI3K inhibitor LY294002 from Merck Millipore, Billerica, MA, USA; 
pinosylvin, monomethyl pinosylvin and resveratrol from Sequoia Research Products, 
Pangbourne, UK; pterostilbene, piceatannol and dexamethasone from Orion Pharma, Finland; 
rhapontigenin from Cayman Chemical, MI, USA; astringin from Polyphenols Laboratories, 
Norway, and rhaponticin from Sigma Aldrich, MO, USA. 
Chemistry 
General experimental details 
Commercially available reagents were used without further purification: all solvents were 
anhydrous and HPLC grade, purchased from Sigma-Aldrich (St. Gallen, Switzerland). All 
reactions were performed in oven-dried glassware under an inert atmosphere of dry argon. 
Thin layer chromatography (TLC) was performed on E. Merck Silica Gel 60 aluminium 
packed plates, visualization accomplished by UV illumination and staining with H2SO4 (5% 
v/v) in MeOH. 
1
H NMR spectra were recorded on a Varian Mercury-VX 300 MHz with 
chemical shifts reported as parts per million (in acetone-d6 at 23 °C, solvent peak at 2.05 ppm 
as an internal standard). 
13
C NMR spectra were obtained on a Varian Mercury-VX 75 MHz 
spectrometer with chemical shifts reported as parts per million (acetone-d6 at 23 °C, solvent 
peaks at 29.84, and 206.26 ppm as an internal standard). 
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Synthesis of pinosylvin monoethers 
General procedure: A mixture of pinosylvin (0.050 g, 0.24 mmol), potassium carbonate 
(0.050 g, 0.36 mmol), and alkyl or allyl bromide (0.36 mmol) in acetone (3-5 mL) was 
refluxed under argon for 24 hours. The reaction mixture was poured into water and extracted 
with diethyl ether. The organic layer was washed with brine, dried over anhydrous Na2SO4, 
and concentrated in vacuo. The crude products were purified with silica column eluting with 
10-30 % hexanes/EtOAc to give monoethers in 8-28 % yields. Pinosylvin monoethyl ether 
(9): Off-white crystals (10.7 mg, 29%). Rf = 0.76 (n-hexane/EtOAc = 1:1).
 1
H NMR (300 
MHz, acetone-d6) δ 8.32 (s, 1H), 7.58 (m, 2H), 7.27 (m, 1H), 7.36 (m, 2H), 7.15 (d, J = 4.5 
Hz, 2H), 6.68 (m, 2H), 6.35 (t, J = 2.2 Hz, 1H), 4.04 (q, J = 7 Hz, 2H), 1.35 (t, J = 7 Hz, 3H). 
Pinosylvin monopropyl ether (10):
 
Starting from 69 mg (0.33 mmol) of pinosylvin as well 
as using 44 µL (0.49 mmol, 1.5 equiv) of 1-bromopropane, and 0.22 g of K2CO3 (1.6 mmol): 




H NMR (300 MHz, 
acetone-d6) δ 8.31 (s, 1H), 7.59 (m, 2H), 7.36 (m, 2H), 7.25 (m, 1H), 7.15 (d, J = 4.2 Hz, 2H), 
6.68 (m, 2H), 6.36 (t, J = 2.2 Hz, 1H), 3.95 (t, J = 6.5 Hz 2H), 1.78 (m, 2H), 1.03 (t, J = 7.4 
Hz, 3H); 
13
C NMR (75 MHz, acetone-d6) δ 161.0, 158.9, 139.7, 137.7, 129.0, 128.8, 128.8, 
127.8, 127.7, 126.7, 106.3, 104.3, 101.7, 69.3, 22.6, 10.1. Pinosylvin monoallyl ether (11): 




H NMR (300 MHz, 
acetone-d6) δ 8.34 (s, 1H), 7.58 (m, 2H), 7.37 (m, 2H), 7.25 (m, 1H), 7.15 (d, J = 4.7 Hz, 2H), 
6.70 (m, 2H), 6.39 (t, J = 2.2 Hz, 1H), 6.06 (m, 1H), 5.43 (dq, J = 17.3, 1.5 Hz, 1H), 5.25 (dq, 
J = 10.6, 1.5 Hz, 1H), 4.57 (dt, J = 5.2, 1.6 Hz, 3H); 
13
C NMR (75 MHz, acetone-d6) δ 160.5, 
158.9, 139.7, 137.7, 134.2, 129.0, 128.9, 128.8, 127.8, 126.7, 116.6, 106.6, 104.5, 102.0, 
68.6. Pinosylvin monoisobutyl ether (12): White crystals (4.8 mg, 7.5%). Rf = 0.77 (n-
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H NMR (300 MHz, acetone-d6) δ 8.29 (s, 1H), 7.58 (m, 2H), 7.37 (m, 
2H), 7.25 (m, 1H), 7.15 (d, J = 4.5 Hz, 2H), 6.69 (m, 2H), 6.37 (t, J = 2.2 Hz, 1H), 3.77 (d, J 
= 6.5 Hz, 2H), 2.06 (m, 1H), 1.03 (d, J = 6.5 Hz, 6H);
 13
C NMR (75 MHz, acetone-d6) δ 
161.1, 158.9, 139.7, 137.7, 129.0, 128.8, 128.8, 127.7, 126.7, 106.3, 104.4, 101.8, 74.3, 18.8. 





H NMR (300 MHz, acetone-d6) δ 8.37 (s, 1H), 7.62 – 7.54 (m, 2H), 
7.53 – 7.47 (m, 2H), 7.45 – 7.31 (m, 5H), 7.30 – 7.19 (m, 1H), 7.16 (d, J = 4.7 Hz, 2H), 6.82 
(dd, J = 7.2, 5.5 Hz, 1H), 6.76 – 6.65 (m, 1H), 6.45 (t, J = 2.2 Hz, 1H), 5.22 – 5.03 (m, 2H);
 
13
C NMR (75 MHz, acetone-d6) δ 161.3, 159.6, 144.6, 140.5, 138.5, 138.3, 132.1, 129.6, 
129.5, 129.3, 128.6, 128.4, 127.4, 124.8, 107.4, 105.3, 102.8, 70.5. 
Anti-inflammatory testing 
Cell culture 
Murine J774 macrophages (American Type Culture Collection, Manassas, VA, USA) were 
cultured at 37 °C in 5% CO2 atmosphere in Dulbecco’s modified Eagle’s medium with 
Ultraglutamine 1 (Sigma-Aldrich, MO, USA) supplemented with 10% heat-inactivated foetal 
bovine serum, 100 U/mL penicillin, 100 µg/mL streptomycin and 250 ng/mL amphotericin B 
(all from Invitrogen, Paisley, UK). Cells were cultured on 24-well plates for western blot, 
ELISA, and nitrite measurements and on 96-well plates for cytotoxicity testing. Cells were 
grown for 72 h to confluence prior to the experiments. 
Cytotoxicity of tested compounds was ruled out by measuring cell viability using Cell 
Proliferation Kit II (Roche Diagnostics, Mannheim, Germany). 
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The effects of the tested compounds on cellular NO production was investigated by 
measuring the accumulation of nitrite (NO2
−
, a stable metabolite of NO), in the cell culture 
medium with the Griess test
43
. 
IL6 and MCP1 ELISA 
IL6 and MCP1 concentrations in the cell culture medium and paw tissue extracts were 
measured by enzyme linked immunosorbent assay (ELISA) using reagents from R&D 
Systems Europe Ltd (Abingdon, UK). 
Western blotting 
At indicated time points, cells were rapidly washed with ice-cold phosphate-buffered saline 
(PBS, pH 7.4) and lysed with a buffer containing 10 mM Tris-base (pH 7.4), 5 mM EDTA, 
50 mM NaCl, 1% Triton X-100, 0.5 mM phenylmethylsulfonyl fluoride, 1 mM sodium 
orthovanadate, 20 µg/mL leupeptin, 50 µg/mL aprotinin, 5 mM NaF, 2 mM sodium 
pyrophosphate and 10 µM n-octyl-β-D-glucopyranoside. After incubation for 15 min on ice, 
cell lysates were centrifuged (13 000g, 4 °C, 10 min), supernatants were collected and stored 
in -20 °C in SDS sample buffer containing 0.5 M Tris (pH 6.8), glycerol (10% v/v), SDS (2% 
v/v), bromophenol blue (0.25‰ v/v) and 2-mercaptoethanol (5% v/v). An aliquot of the 
supernatant was used to determine protein concentration with the Bradford protein assay
44
. 
Protein samples (20 µg of total protein from lysates) were analysed according to standard 
western blotting protocol as described previously.
45
 The membrane was incubated with the 
primary antibody in the blocking solution at 4 °C overnight, and with the secondary antibody 
in the blocking solution for 1 h at room temperature. Bound antibody was detected using 
Super Signal® West Pico or Dura chemiluminescent substrate (Pierce, Rockford, USA) and 
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Image Quant LAS 4000 imaging system (GE Healthcare Bio-Sciences, Buckinghamshire 
UK). The quantitation of the chemiluminescent signal was carried out with the use of Image 
Quant TL software (GE Healthcare). 
Carrageenan-induced paw edema in mice 
The in vivo anti-inflammatory effects of PI3K inhibitor LY294002 and different stilbenoids 
were studied by measuring carrageenan-induced paw edema in male C57BL/6 mice. The 
study was carried out in accordance with the legislation for the protection of animals used for 
scientific purposes (directive 2010/63/EU) and approved by the National Animal Experiment 
Board (approval number ESAVI/5019/04.10.03/2012, granted September 3, 2012). Paw 
edema was induced under anaesthesia and all efforts were made to minimize suffering. 
Animals were housed under conditions of optimum light, temperature and humidity (12:12 h 
light:dark cycle, 22±1 °C, 50–60% humidity) with food and water provided ad libitum. One 
hour prior to carrageenan injection the investigated compounds were delivered i.p. dissolved 
in a vehicle containing 10% DMSO in PBS (pH 7.4). The mice were anesthetised by 
intraperitoneal injection of 0.5 mg/kg of medetomide (Domitor® 1 mg/mL, Orion Oyj, 
Espoo, Finland) and 75 mg/kg of ketamine (Ketalar® 10 mg/mL, Pfizer Oy Animal Health, 
Helsinki, Finland), and thereafter the mice received a 50-µL intradermal injection in one 
hindpaw of normal saline containing λ-carrageenan (1.5% w/v). The contralateral paw 
received 50 µL of saline only and it was used as a control. Edema was measured before and 
three and six hours after carrageenan injection with a plethysmometer (Ugo Basile, Comerio, 
Italy). 
At six hours the mice were sacrificed and the paw tissue injected with carrageenan and the 
contralateral tissue injected with the vehicle was collected for analysis into a buffer 
containing Tris (50 mM, pH 7.4), NaCl (150 mM), and protease and phosphatase inhibitors 
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phenylmethylsulfonyl fluoride (0.5 mM), sodium orthovanadate (2 mM), leupeptin (0.10 
µg/mL), aprotinin (0.25 µg/mL) and NaF (1.25 mM). The tissue was minced and centrifuged 
(10 min, 10 000g) and the supernatant was collected for ELISA measurements. 
Statistics 
Results are expressed as mean+standard error of mean (S.E.M.). Statistical significance of the 
results was calculated by one-way ANOVA with Dunnett’s or Bonferroni’s post-test. 
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Figure 1: The molecular structures of the studied natural and semi-synthetic stilbenoids.  
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Figure 2: LPS-stimulated phosphorylation of Akt in activated macrophages. J774 macrophages were 
stimulated with bacterial lipopolysaccharide (LPS, 10 ng/mL) in the absence or in the presence of 10 µM 
LY294002 for 4 hours. Thereafter cellular proteins were extracted and the level of Akt phosphorylation was 
measured by Western blotting with an antibody specific towards phosphorylated S473 residue. Values are 
mean + S.E.M., n = 4, **p < 0.01.  
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Figure 3: The concentration-dependent effect of natural stilbenoids and stilbenoid glycosides on Akt 
phosphorylation in activated macrophages. J774 macrophages were stimulated with bacterial 
lipopolysaccharide (LPS, 10 ng/mL) for 4 hours in the presence of increasing concentrations of (A) pinosylvin 
(1), (B) monomethyl pinosylvin (2), (C) resveratrol (3), (D) pterostilbene (4), (E) piceatannol (5) and 
astringin (7), and (F) rhapontigenin (6) and rhaponticin (8). Thereafter cellular proteins were extracted and 
the level of Akt phosphorylation was investigated by western blotting with an antibody specific towards 
phosphorylated S473 residue. Values are mean + S.E.M., n = 4-6, *p < 0.05 and **p < 0.01.  
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Figure 4. The effect of semi-synthetic pinosylvin derivatives on Akt phosphorylation in activated 
macrophages. J774 macrophages were stimulated with bacterial lipopolysaccharide (LPS, 10 ng/mL) for 4 
hours in the presence of the semi-synthetic stilbenoids 9-13 (30 µM). Pinosylvin and LY294002 were used as 
reference compounds. After incubation cellular proteins were extracted and Akt phosphorylation was 
investigated by Western blotting with an antibody specific towards phosphorylated S473 residue. Values are 
mean + S.E.M., n = 4, **p < 0.01.  
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Figure 5: The effects of natural stilbenoids on NO production in activated macrophages. J774 macrophages 
were stimulated with bacterial lipopolysaccharide (LPS, 10 ng/mL) in the presence of increasing 
concentrations of (A) pinosylvin (1), (B) monomethyl pinosylvin (2), (C) resveratrol (3), (D) pterostilbene 
(4), (E) piceatannol (5) and (F) rhapontigenin (6) for 24 hours. After incubation the cell culture media were 
collected. NO production was investigated by measuring the accumulation of its stabile metabolite nitrite in 
the cell culture media with the Griess method. In addition, the effects of stilbenoid glycosides astringin (7) 
and rhaponticin (8) on NO production were investigated and compared to their aglycones (G). LY29004 was 
used as a reference compound (H). Values are mean + S.E.M., n = 4, *p < 0.05 and **p < 0.01.  
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Figure 6: The effects of natural stilbenoids on IL6 expression in activated macrophages. J774 macrophages 
were stimulated with bacterial lipopolysaccharide (LPS, 10 ng/mL) in the presence of increasing 
concentrations of (A) pinosylvin (1), (B) monomethyl pinosylvin (2), (C) resveratrol (3), (D) pterostilbene 
(4), (E) piceatannol (5) and (F) rhapontigenin (6) for 24 hours. After incubation the cell culture media were 
collected and IL6 concentrations were measured with ELISA. In addition, the effects of stilbenoid glycosides 
astringin (7) and rhaponticin (8) on IL6 production were measured investigated and compared to their 
aglycones (G). LY29004 was used as a reference compound (H). Values are mean + S.E.M., n = 4, *p < 
0.05 and **p < 0.01.  
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Figure 7: The effects of natural stilbenoids on MCP1 expression in activated macrophages J774 macrophages 
were stimulated with bacterial lipopolysaccharide (LPS, 10 ng/mL) in the presence of increasing 
concentrations of (A) pinosylvin (1), (B) monomethyl pinosylvin (2), (C) resveratrol (3), (D) pterostilbene 
(4), (E) piceatannol (5) and (F) rhapontigenin (6) for 24 hours. After incubation the cell culture media were 
collected and the concentrations of MCP1 were measured with ELISA. In addition, the effects of stilbenoid 
glycosides astringin (7) and rhaponticin (8) on MCP1 production were measured and compared to their 
aglycones (G). LY29004 was used as a reference compound (H). Values are mean + S.E.M., n = 4, **p < 
0.01.  
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Figure 8: The effects of natural stilbenoids in the carrageenan-induced paw inflammation model in the 
mouse. The investigated stilbenoids pterostilbene (4), pinosylvin (1) and piceatannol (5) (all 30 mg/kg) or 
the PI3K inhibitor LY294002 (15 mg/kg) or dexamethasone (2 mg/kg) were administered to the animals 
intraperitoneally 2 hours prior to carrageenan (1.5% in saline) was injected into the paw, and saline was 
injected into the contralateral paw to serve as a control. Paw edema was measured before, and 3 and 6 
hours after carrageenan injection. Edema is expressed as the difference between the volume changes of the 
carrageenan-treated paw and the control paw (injected with saline). Values are mean + S.E.M., n = 6 
(stilbenoids) or 7 (dexamethasone and LY294002), *p < 0.05 and **p < 0.01.  
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Figure 9: The effects of natural stilbenoids on the expression of the inflammatory cytokines IL6 and MCP1 in 
the carrageenan-induced paw inflammation model in the mouse. The investigated stilbenoids pterostilbene 
(4), pinosylvin (1) and piceatannol (5) (all 30 mg/kg) or the PI3K inhibitor LY294002 (15 mg/kg) or 
dexamethasone (2 mg/kg) were administered to the animals intraperitoneally 2 hours prior to carrageenan 
(1.5% in saline) was injected into the paw, and saline was injected into the contralateral paw to serve as a 
control. Six hours after carrageenan exposure the animals were sacrificed and the paw tissue was extracted. 
The expression of IL6 and MCP1 in the tissue was measured with ELISA. Values are mean + S.E.M., n = 6 
(stilbenoids) or 7 (dexamethasone and LY294002), *p < 0.05 and **p < 0.01.  
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